皮肤填充剂市场－全球产业规模、份额、趋势、机会和预测：按类型、材料类型、应用、性别、最终用户、地区和竞争格局划分，2021-2031年

全球皮肤填充剂市场预计将从 2025 年的 78.1 亿美元成长到 2031 年的 123.8 亿美元，复合年增长率为 7.98%。

这些可注射的凝胶状物质用于美容嫩肤，以减少皱纹、改善脸部轮廓并恢復流失的容量。市场成长的主要驱动力是全球人口老化以及消费者对非侵入性、恢復期短、效果立竿见影的美容方案的强烈偏好。然而，由于不良副作用和併发症的风险，该行业面临着巨大的挑战，这需要严格的监管，并且可能会让谨慎的患者望而却步。

根据国际美容整形外科学会的数据，预计到2024年，全球整体使用玻尿酸的整形手术数量将增加5.2%，达到630万例。这项数据凸显了整个美容医学领域对软组织填充的持续需求。

市场驱动因素

推动全球皮肤填充剂市场成长的关键因素是人们对微创、非手术美容疗程的需求日益增长。由于恢復时间更快、併发症风险更低以及效果更立竿见影，患者越来越倾向于选择注射疗法而非手术。美国整形外科医师协会于2024年6月发布的《2023年整形外科统计报告》印证了这一趋势，该报告记录了超过530万例透明质酸填充剂注射。此外，区域成长也十分强劲。英国美容整形外科医师协会于2024年4月发布的《2023年年度审核报告》显示，其会员所进行的非手术皮肤填充剂注射数量较去年同期增加了27%。

此外，填充配方方面的技术创新，例如先进的交联技术和能够刺激胶原蛋白生成并改善皮肤品质的生物刺激产品，正在推动市场扩张。这些进步使得针对更广泛患者群体的个人化治疗成为可能，从丰唇到深度塑形，不一而足。这些创新带来的财务影响显而易见：高德美公司于2024年10月发布的「2024年第三季」业绩报告显示，其註射美容部门的净销售额按外汇计算同比增长10.6%，这主要得益于全球市场对公司产品系列的需求。

市场挑战

全球皮肤填充剂市场面临的主要障碍之一是持续存在的併发症和不良副作用风险，这不仅需要严格的监管，也导致消费者犹豫不决。随着市场成长，无证件从业人员和不受监管的产品也随之增多，同时，与手术相关的损伤，例如严重感染疾病和血管阻塞，也日益增多。这些安全问题削弱了消费者的信心，并迫使各国政府实施严格的核准通讯协定和执业限制，从而提高了市场准入门槛，延缓了产品商业化进程。

这些安全问题的严重性在修订资料中显而易见。英国美容医学学院报告称，其成员在2024年处理了3547例由其他从业人员造成的併发症，这表明存在大量不合格的治疗结果。这些问题的曝光加剧了潜在患者的风险规避心理，限制了潜在市场，并持续限制产业发展。

市场趋势

重塑市场格局的关键趋势之一是男性美容疗程的激增。越来越多的男性寻求透过注射填充剂来增强脸部男性特征并塑造轮廓。女性患者往往更注重中部容量的提升，而男性则越来越追求更清晰、更有型的下颚线和下巴，打破了传统的性别刻板印象。美国面部整形与重组外科协会于2025年2月发布的《2024年度调查统计数据》凸显了这一转变，数据显示，92%的外科医生表示曾治疗过男性患者，表明该手术已被广泛接受。

同时，消费者越来越倾向于低调自然的美容效果，这推动了对能够提升而非改变个人面部特征的微调的需求。患者逐渐摒弃了过度填充带来的不自然效果，转而选择微剂量注射技术，这种技术能够在保持脸部弹性的同时，带来不易察觉的改善。 Merz Aesthetics 于 2025 年 1 月进行的「自信基石」调查也印证了这种对自然美的追求，其中 69% 的受访者表示他们希望接受的治疗能够「反映他们的内心感受」。这表明，人们越来越倾向于将内在自我与外在形象相协调。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球皮肤填充剂市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（可生物降解、不可生物降解）
  • 依材料种类（透明质酸、烃基磷灰石钙、聚左旋乳酸、聚甲基丙烯酸甲酯微粒[PMMA]、其他）
  • 依应用领域（除皱治疗、脸部细纹矫正、拉皮、丰唇、疤痕治疗）
  • 性别（女性与男性）
  • 按最终使用者（皮肤科诊所、医院、美容诊所等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美皮肤填充剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

7. 欧洲皮肤填充剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区皮肤填充剂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲皮肤填充剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲皮肤填充剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球皮肤填充剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• AbbVie Inc.
• Galderma SA
• Merz Pharmaceuticals GmbH
• Revance Therapeutics, Inc.
• Huadong Medicine Co., Ltd.
• Teoxane SA
• Anika Therapeutics, Inc.
• Suneva Medical, Inc.
• BioPlus Co., Ltd.
• Prollenium Medical Technologies

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dermal Fillers Market is projected to expand from USD 7.81 Billion in 2025 to USD 12.38 Billion by 2031, reflecting a compound annual growth rate of 7.98%. These injectable gel-like substances are utilized for aesthetic rejuvenation, aiming to smooth lines, enhance facial contours, and restore lost volume. Market growth is largely fueled by a global aging population and a notable consumer preference for non-invasive cosmetic options that provide immediate results with little downtime. However, the industry encounters significant challenges due to the risk of adverse side effects and complications, which require rigorous regulatory monitoring and may discourage cautious patients.

According to the International Society of Aesthetic Plastic Surgery, hyaluronic acid procedures increased by 5.2 percent in 2024, reaching a total of 6.3 million procedures globally. This data highlights the enduring demand for soft tissue augmentation within the broader field of aesthetic medicine.

Market Driver

The primary force driving the Global Dermal Fillers Market is the escalating demand for minimally invasive and non-surgical aesthetic treatments. Patients increasingly favor injectables over surgical alternatives due to shorter recovery periods, lower complication risks, and more immediate visual results. This preference is evidenced by the American Society of Plastic Surgeons' '2023 Plastic Surgery Statistics Report' released in June 2024, which recorded over 5.3 million hyaluronic acid filler procedures. Additionally, regional growth is robust; the British Association of Aesthetic Plastic Surgeons noted in their April 2024 'Annual Audit 2023' that non-surgical dermal filler treatments among members rose by 27 percent from the previous year.

Market expansion is further catalyzed by technological innovations in filler formulations, including advanced cross-linking techniques and biostimulatory products that enhance skin quality by stimulating collagen production. These developments allow for tailored treatments ranging from lip augmentation to deep structural contouring, broadening the patient base. The financial impact of these innovations is clear, as Galderma reported in its 'Third Quarter 2024 Financial Results' in October 2024 that net sales for its Injectable Aesthetics unit increased by 10.6 percent year-on-year on a constant currency basis, fueled by global demand for its portfolio.

Market Challenge

The main obstacle facing the Global Dermal Fillers Market is the ongoing risk of complications and adverse side effects, which necessitates strict regulatory control and causes consumer hesitation. As the market grows, an increase in unqualified practitioners and unregulated products has led to procedure-related injuries such as severe infections and vascular occlusions. These safety issues undermine consumer trust and force governments to enforce rigorous approval protocols and practice restrictions, creating barriers to entry and slowing product commercialization.

The magnitude of these safety challenges is underscored by data on corrective treatments. The British College of Aesthetic Medicine reported in 2024 that its members treated 3,547 complications caused by other practitioners, indicating a significant volume of substandard outcomes. The visibility of such issues reinforces risk aversion among potential patients, limiting the addressable market and acting as a continuous restraint on industry growth.

Market Trends

A significant trend reshaping the market is the surge in male aesthetic treatments, with men increasingly seeking dermal fillers for facial masculinization and structural contouring. Unlike female patients who may focus on mid-face volume, male demographics often seek to project a stronger jawline and chin for a more defined look, breaking down historical stigmas. This shift is highlighted by the American Academy of Facial Plastic and Reconstructive Surgery's '2024 Annual Survey Statistics' from February 2025, in which 92 percent of surgeons reported treating male patients, signaling widespread normalization.

Concurrently, there is a growing consumer preference for subtle, natural-looking outcomes, driving demand for 'tweakments' that enhance rather than alter individual anatomy. Patients are moving away from overfilled appearances in favor of micro-dosing techniques that maintain facial mobility and provide undetectable improvements. This desire for authenticity is supported by Merz Aesthetics' 'Pillars of Confidence' study from January 2025, where 69 percent of respondents expressed a desire for treatments that reflect their inner feelings, emphasizing a shift toward personal congruency.

Key Market Players

• AbbVie Inc.
• Galderma S.A.
• Merz Pharmaceuticals GmbH
• Revance Therapeutics, Inc.
• Huadong Medicine Co., Ltd.
• Teoxane S.A.
• Anika Therapeutics, Inc.
• Suneva Medical, Inc.
• BioPlus Co., Ltd.
• Prollenium Medical Technologies

Report Scope

In this report, the Global Dermal Fillers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermal Fillers Market, By Type

• Biodegradable
• Non-Biodegradable

Dermal Fillers Market, By Material Type

• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid
• Polymethyl-methacrylate Microspheres [PMMA]
• Others

Dermal Fillers Market, By Application

• Wrinkle Correction Treatment
• Facial Line Correction
• Face Lift
• Lip Enhancement
• Scar Treatment

Dermal Fillers Market, By Gender

• Female
• Male

Dermal Fillers Market, By End User

• Dermatology Clinics
• Hospitals
• Beauty Clinics
• Others

Dermal Fillers Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermal Fillers Market.

Available Customizations:

Global Dermal Fillers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermal Fillers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Biodegradable, Non-Biodegradable)
  • 5.2.2. By Material Type (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres [PMMA], Others)
  • 5.2.3. By Application (Wrinkle Correction Treatment, Facial Line Correction, Face Lift, Lip Enhancement, Scar Treatment)
  • 5.2.4. By Gender (Female v/s Male)
  • 5.2.5. By End User (Dermatology Clinics, Hospitals, Beauty Clinics, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Dermal Fillers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Material Type
  • 6.2.3. By Application
  • 6.2.4. By Gender
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dermal Fillers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Material Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Gender
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Dermal Fillers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Material Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Gender
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Dermal Fillers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Material Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Gender
      • 6.3.3.2.5. By End User

7. Europe Dermal Fillers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Material Type
  • 7.2.3. By Application
  • 7.2.4. By Gender
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dermal Fillers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Material Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Gender
      • 7.3.1.2.5. By End User
  • 7.3.2. France Dermal Fillers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Material Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Gender
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Dermal Fillers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Material Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Gender
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Dermal Fillers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Material Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Gender
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Dermal Fillers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Material Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Gender
      • 7.3.5.2.5. By End User

8. Asia Pacific Dermal Fillers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Material Type
  • 8.2.3. By Application
  • 8.2.4. By Gender
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dermal Fillers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Material Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Gender
      • 8.3.1.2.5. By End User
  • 8.3.2. India Dermal Fillers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Material Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Gender
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Dermal Fillers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Material Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Gender
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Dermal Fillers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Material Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Gender
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Dermal Fillers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Material Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Gender
      • 8.3.5.2.5. By End User

9. Middle East & Africa Dermal Fillers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Material Type
  • 9.2.3. By Application
  • 9.2.4. By Gender
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dermal Fillers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Material Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Gender
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Dermal Fillers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Material Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Gender
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Dermal Fillers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Material Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Gender
      • 9.3.3.2.5. By End User

10. South America Dermal Fillers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Material Type
  • 10.2.3. By Application
  • 10.2.4. By Gender
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dermal Fillers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Material Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Gender
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Dermal Fillers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Material Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Gender
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Dermal Fillers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Material Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Gender
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dermal Fillers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. AbbVie Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Galderma S.A.
• 15.3. Merz Pharmaceuticals GmbH
• 15.4. Revance Therapeutics, Inc.
• 15.5. Huadong Medicine Co., Ltd.
• 15.6. Teoxane S.A.
• 15.7. Anika Therapeutics, Inc.
• 15.8. Suneva Medical, Inc.
• 15.9. BioPlus Co., Ltd.
• 15.10. Prollenium Medical Technologies

16. Strategic Recommendations

17. About Us & Disclaimer